Symposium

Social Research, Policy, and Practice

Session Title: Using Real-World Evidence to Support the FDA Regulatory Approval: Methodological Considerations

3 - Use of RWD to Generate RWE in the Alzheimer's Disease Setting: Challenges and Future Directions

Friday, November 4, 2022

8:00 AM – 9:30 AM ET

Location: 236 CC

Individual Symposium Abstract First Author: Julia DiBello, PhD, Merck & Co., Inc.

Individual Symposium Abstract First Author(s)

Julia R. DiBello, PhD
Sr. Principal Scientist
Merck & Co., Inc.
West Point, Pennsylvania, United States